chlorpropamide has been researched along with Acidosis, Renal Tubular, Type I in 1 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radó, JP | 1 |
| Szabó, T | 1 |
| Szende, L | 1 |
| Takó, J | 1 |
| Dévényi, I | 1 |
| Hutás, I | 1 |
| Gartner, P | 1 |
| Gergely, R | 1 |
1 other study available for chlorpropamide and Acidosis, Renal Tubular, Type I
| Article | Year |
|---|---|
Excessive decrease in free water clearance induced by furosemide and ethacrynic acid in nephrogenic diabetes insipidus associated with renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Adult; Chlorpropamide; Diabetes Insipidus; Ethacrynic Acid; Female; Furosem | 1973 |